Lantus and Basaglar are approved to improve blood sugar management in adults with type 1 or type 2 diabetes. And it’s also approved for these uses in children ages 6 years or older. Toujeo is FDA-approved to improve blood sugar management in adults with type 1 or type 2 diabetes. But you should not switch medications without your doctor’s guidance.)įor comparison information about Toujeo with other drugs, see the “Toujeo vs. (However, you can use Basaglar in place of Lantus, and vice versa. So, you can’t use Toujeo in place of Lantus or Basaglar, and you can’t use Lantus or Basaglar in place of Toujeo. While Toujeo, Lantus, and Basaglar contain the same active drug, the main difference between them is that Toujeo is more concentrated than either Lantus or Basaglar. Specifically, each of these medications contains the same ingredient, insulin glargine. Toujeo, Lantus, and Basaglar are all brand-name drugs that contain a long-acting insulin. The ADA recommends a A1C goal of less than 7.0% for most adults.įor more information on Toujeo’s effectiveness, see the section below called “Toujeo uses.” †A1C is a measurement that shows your average blood sugar levels over the past 2 to 3 months. The American Diabetes Association (ADA) recommends a fasting blood sugar level of 80 mg/dL to 130 mg/dL for most adults. * Fasting blood sugar is measured after you’ve fasted for a certain time. The study found that after 26 weeks of treatment, Toujeo lowered the children’s: hemoglobin A1c (A1C) levels † by 0.4% to 1.42%Ī clinical study also tested Toujeo in children ages 6 years or older with type 1 diabetes.fasting blood sugar levels* by 17 to 61 mg/dL.The studies showed that after 26 weeks of treatment, Toujeo lowered the people’s: It can give up to 160 units of insulin glargine in a single injection.Ĭlinical studies tested Toujeo in adults with type 1 or type 2 diabetes. This pen contains 900 units of insulin glargine in 3 mL of solution. It can give up to 80 units of insulin glargine in a single injection. This pen contains 450 units of insulin glargine in 1.5 mL of solution. It’s available in the following two prefilled pens: This drug is given as a subcutaneous injection (an injection under your skin). Toujeo contains insulin glargine, which is a long-acting insulin. It’s FDA-approved to treat type 1 or type 2 diabetes in adults and children ages 6 years and older. Toujeo is a brand-name prescription medication.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |